Skip to main content
Clinical Trials/NCT01059331
NCT01059331
Completed
Phase 4

Perioperative Administration of Pregabalin in Laparoscopic Living Donor Nephrectomy (L-LDN) - an Adjuvance to Peroral Analgetic Treatment - a Randomized Controlled Study

Oslo University Hospital1 site in 1 country80 target enrollmentFebruary 2010

Overview

Phase
Phase 4
Intervention
Pregabalin
Conditions
Living Donors
Sponsor
Oslo University Hospital
Enrollment
80
Locations
1
Primary Endpoint
Opioid consumption in milligrams Pain Score given as Numeric Rating Scale (NRS)
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The aim of the study is to investigate if perioperative administration of pregabalin vil reduce postoperative pain and the postoperative need for intravenous opioids compared with todays standard treatment which consist of paracetamol, corticoids and ketobemidone.

In addition potential sideeffects as sedation and effect on cognitive function will be recorded.

Registry
clinicaltrials.gov
Start Date
February 2010
End Date
December 2012
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Oslo University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Marianne Myhre

cand.med.

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • \>18, \< 75 years
  • healthy patients accepted for laparoscopic living donor nephrectomy

Exclusion Criteria

  • not familiar to the Norwegian language (spoken and written)
  • allergic to one or more of the medication given in the study

Arms & Interventions

Pregabalin

Intervention: Pregabalin

Sugar pill

Intervention: Sugar pill

Outcomes

Primary Outcomes

Opioid consumption in milligrams Pain Score given as Numeric Rating Scale (NRS)

Time Frame: Daily troughout the hospital stay, approx. 6 days

Secondary Outcomes

  • Sedation and cognitive function(Daily troughout the hospital stay, approx. 6 days)

Study Sites (1)

Loading locations...

Similar Trials